Antithrombotic therapy and risk of intracranial hemorrhage in patients with cerebral cavernous malformations: a multicenter propensity-matched cohort study - PubMed
3 hours ago
- #Cerebral Cavernous Malformations
- #Intracranial Hemorrhage
- #Antithrombotic Therapy
- Antithrombotic therapy in cerebral cavernous malformation patients without prior intracranial hemorrhage is linked to an increased risk of intracranial hemorrhage.
- The study found a higher incidence of seizures, inpatient readmission, and emergency department visits in patients on antithrombotic therapy compared to those not on therapy.
- Subgroup analysis revealed anticoagulants specifically increased the risk of intracranial hemorrhage, whereas antiplatelet agents did not show a significant increase.